登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Complement C2】

Complement C2信息

英文名称:Complement C2
中文名称:补体C2
靶点别称:C3/C5 convertase
上市药物数量:0
临床药物数量:1
最高研发阶段:临床二期

Complement C2分子别名

C2,Complement C2,Complement Component C2

Complement C2分子背景

C2 is a major histocompatibility complex class-III protein. Component C2 which is part of the classical pathway of the complement system is cleaved by activated factor C1 into two fragments: C2b and C2a. C2a, a serine protease, then combines with complement factor C4b to generate the C3 or C5 convertase. The lectin (LP) and classical (CP) pathways are two of the three main activation cascades of the complement system. These pathways start with recognition of different pathogen- or danger-associated molecular patterns and include identical steps of proteolytic activation of complement component C4, formation of the C3 proconvertase C4b2, followed by cleavage of complement component C2 within C4b2 resulting in the C3 convertase C4b2a.

Complement C2临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
empasiprubart ARGX-117 临床二期 Argenx Se, Broteio Pharma BV 运动神经元病, 周围神经系统疾病, 皮肌炎, 肌炎, 新型冠状病毒感染, 移植物功能延迟恢复 详情

消息提示

请输入您的联系方式,再点击提交!

确定